Novavax NVAX announced that it has started dosing participants in the phase III study evaluating its experimental ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.02 which represents a slight increase of $0.20 or 2.27% from the prior close of $8.82. The stock opened at $8.77 and touched a low of ...

Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...

Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has ...

Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Vernon Bernardino, an analyst from H.C. Wainwright, maintained the Buy rating on Novavax (NVAX – Research Report). The associated price target ...

On Tuesday, Novavax Inc (NVAX) stock saw a decline, ending the day at $8.77 which represents a decrease of $-0.30 or -3.31% from the prior close of $9.07. The stock opened at $9.1 and touched a low of ...

As of 12:32:01 PM EST. Market Open. Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the first participants have ...

Shares of Novavax Inc. NVAX slid 3.31% to $8.77 Tuesday, on what proved to be an all-around poor trading session for the ...

Novavax Inc. closed $15.04 short of its 52-week high ($23.86), which the company reached on June 6th.

Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at Zacks Research dropped their FY2024 earnings ...